These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9089849)

  • 1. Acute effects of triazolam in women: relationships with progesterone, estradiol and allopregnanolone.
    de Wit H; Rukstalis M
    Psychopharmacology (Berl); 1997 Mar; 130(1):69-78. PubMed ID: 9089849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of triazolam at three phases of the menstrual cycle.
    Rukstalis M; de Wit H
    J Clin Psychopharmacol; 1999 Oct; 19(5):450-8. PubMed ID: 10505587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.
    Andréen L; Sundström-Poromaa I; Bixo M; Andersson A; Nyberg S; Bäckström T
    Psychoneuroendocrinology; 2005 Feb; 30(2):212-24. PubMed ID: 15471618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women.
    Justice AJ; de Wit H
    Psychopharmacology (Berl); 1999 Jul; 145(1):67-75. PubMed ID: 10445374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopregnanolone and mood disorders.
    Bäckström T; Bixo M; Johansson M; Nyberg S; Ossewaarde L; Ragagnin G; Savic I; Strömberg J; Timby E; van Broekhoven F; van Wingen G
    Prog Neurobiol; 2014 Feb; 113():88-94. PubMed ID: 23978486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the discriminative stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women.
    Babalonis S; Emurian CS; Martin CA; Lile JA; Kelly TH
    Drug Alcohol Depend; 2008 Apr; 94(1-3):276-80. PubMed ID: 18178039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators.
    Andréen L; Nyberg S; Turkmen S; van Wingen G; Fernández G; Bäckström T
    Psychoneuroendocrinology; 2009 Sep; 34(8):1121-32. PubMed ID: 19272715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause.
    Kimball A; Dichtel LE; Nyer MB; Mischoulon D; Fisher LB; Cusin C; Dording CM; Trinh NH; Yeung A; Haines MS; Sung JC; Pinna G; Rasmusson AM; Carpenter LL; Fava M; Klibanski A; Miller KK
    Psychoneuroendocrinology; 2020 Feb; 112():104512. PubMed ID: 31780185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopregnanolone concentration and mood--a bimodal association in postmenopausal women treated with oral progesterone.
    Andréen L; Sundström-Poromaa I; Bixo M; Nyberg S; Bäckström T
    Psychopharmacology (Berl); 2006 Aug; 187(2):209-21. PubMed ID: 16724185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women with acute intermittent porphyria have a defect in 5α-steroid production during the menstrual cycle.
    Innala E; Bäckström T; Poromaa IS; Andersson C; Bixo M
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1445-52. PubMed ID: 22924787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects.
    Schmidt PJ; Purdy RH; Moore PH; Paul SM; Rubinow DR
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1256-60. PubMed ID: 7962316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate doses of ethanol fail to increase plasma levels of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one-like immunoreactivity in healthy men and women.
    Holdstock L; Penland SN; Morrow AL; de Wit H
    Psychopharmacology (Berl); 2006 Jun; 186(3):442-50. PubMed ID: 16240164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.
    Bixo M; Johansson M; Timby E; Michalski L; Bäckström T
    J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 29072794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers.
    Freeman EW; Purdy RH; Coutifaris C; Rickels K; Paul SM
    Neuroendocrinology; 1993 Oct; 58(4):478-84. PubMed ID: 7904330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTSD in women is associated with a block in conversion of progesterone to the GABAergic neurosteroids allopregnanolone and pregnanolone measured in plasma.
    Pineles SL; Nillni YI; Pinna G; Irvine J; Webb A; Arditte Hall KA; Hauger R; Miller MW; Resick PA; Orr SP; Rasmusson AM
    Psychoneuroendocrinology; 2018 Jul; 93():133-141. PubMed ID: 29727810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone effects on the discriminative stimulus, subjective and performance effects of triazolam in healthy, premenopausal women.
    Babalonis S; Lile JA; Martin CA; Kelly TH
    Behav Pharmacol; 2011 Sep; 22(5-6):441-9. PubMed ID: 21808190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women.
    de Wit H; Schmitt L; Purdy R; Hauger R
    Psychoneuroendocrinology; 2001 Oct; 26(7):697-710. PubMed ID: 11500251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase.
    White TL; Justice AJ; de Wit H
    Pharmacol Biochem Behav; 2002 Nov; 73(4):729-41. PubMed ID: 12213517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women.
    Wihlbäck AC; Nyberg S; Bäckström T; Bixo M; Sundström-Poromaa I
    Psychoneuroendocrinology; 2005 Jan; 30(1):38-50. PubMed ID: 15358441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.